Good strategy starts with good intelligence. CHASE delivers expert market insights and bespoke research to help commercial, market access and medical affairs leaders across pharmaceutical, medtech and biotech make smarter, faster decisions. Our insight services are grounded in real NHS relationships, live clinical networks and over 25 years of life sciences experience and now, in partnership with HSJ Advisory, backed by licensed NHS data.
Our insight services go beyond data. We bring the context, connections and clinical grounding to turn intelligence into action.
Our insights draw on established relationships with Integrated Care Boards, Primary Care Networks and NHS Trusts built over decades of operational delivery. We don’t just report on the NHS, we work within it.
Through our sister company Medacy, we have direct access to a network of over 60 clinical pharmacists across the UK. Their on-the-ground perspectives on prescribing behaviour, product perceptions and clinical priorities are not available anywhere else.
CHASE sits at the intersection of commercial life sciences and NHS delivery. That position gives us a unique ability to translate clinical realities into commercially relevant intelligence and vice versa.
We don’t offer off-the-shelf reports. Every engagement is designed around your specific questions, markets and strategic priorities and every output is designed to drive decisions, not just inform them.
Key clients receive complimentary access to our annual insights report, exploring the trends, challenges and opportunities shaping UK life sciences. Custom research is also available for more targeted requirements.
Our insight services cover the full range of intelligenceneeds for life sciences organisations operating in the UK.
Equip your customer-facing teams with the skills, tools and strategies they need to excel. Through one-to-one qualitative interviews with field teams, we provide an honest, holistic view of their needs and challenges with practical recommendations for accelerating their performance.
Deepen your understanding of specific therapy areas with insights gathered through our expert research networks and Medacy’s clinical pharmacist community. Tap into the perspectives of over 60 independent prescribers across the UK on how they perceive your products and make therapeutic decisions plus access to a wider field of healthcare professionals where needed.
Engage effectively with NHS systems by drawing on insights from our established relationships with Integrated Care Systems, Integrated Care Boards and Primary Care Networks. Understanding their priorities and pressures enables you to align your solutions with real NHS need.
Gain a deeper understanding of patients’ experiences and challenges with their condition and treatment pathway. Using our expert partner network, we support study design, patient recruitment and data analysis delivering actionable insights that drive patient-focused outcomes.
Access tailored reports and intelligence to stay ahead of changing markets, policies and regulations. Our annual insights report is available to key clients, and bespoke custom research is available for more targeted market access or commercial strategy requirements.
CHASE has partnered with HSJ Advisory to offer senior pharma and medtech leaders a uniquely integrated service for NHS-industry programme design and delivery. HSJ Advisory brings licensed NHS data intelligence and independent validation; CHASE and Medacy bring the clinical teams and operational expertise to make it happen. Together, we bridge the gap between NHS strategy and operational reality.
HSJ Advisory uses licensed NHS Hospital Episode Statistics (HES) and prescribing data to map patient access and align your commercial or clinical proposition with national and local NHS priorities.
HASE and Medacy deploy the expert clinical and commercial teams required to execute the strategy within NHS settings.
HSJ Advisory independently validates programme impact by reviewing hospital activity and prescribing data, providing a level of real-world evidence that global consultancies often cannot replicate.
CHASE ensures the value of the programme outlasts our presence, training NHS staff, embedding automated systems and enabling the NHS to maintain the service independently after our active involvement ends.
Successful outcomes are shared via HSJ’s journals, webinars, events and white papers, establishing your leadership in the therapeutic area with a credible, independent platform.
As independent, UK-based experts, the CHASE and HSJ Advisory partnership combines licensed NHS data, clinical delivery capability and independent real-world evidence — with the agility and accountability that global firms cannot match.
Partner with a leading life science recruitment agency. We provide staffing for clinical operations, MSAT, and medical affairs. 6-week placement benchmark.
"Many thanks for all CHASE’s efforts in leading this important work through an extremely challenging time for the NHS.
Your attention to detail, co-ordination of all the moving parts and ability to drive the project forward has been exemplary.
Albeit we have been delayed by the pandemic, I know we would not have delivered the results achieved so far, without your efforts and for this CHASE deserve massive credit.
My experience has been such that I would highly recommend CHASE as a go-to organisation to deliver both R&D projects, or service improvement initiatives that could benefit both pharma and the wider NHS."
Director of Medicine Engagement
"I wanted to recognise what brilliant partners CHASE have been to our team over the last few months, playing a vital role in helping us deliver this critical project at such high pace.
Steve in the early phases, and then Emma, Huw & Danny as regular members of the Project Team. Huw, of note, your early leadership in the Project Team, leaning on past experience of how to run the process alongside our other supplier was particularly helpful in those first weeks.
To the whole team, your responsiveness, pragmatism and positive energy has been first class throughout."
Commercial Business Unit Director
"CHASE have been trusted partners for over a decade and provide us with a high-quality outsourced specialist sales team, plus excellent wrap around service, pastoral care and consultancy.
When we recently launched a new Oncology product, the CHASE sales team was instrumental in this. I am regularly approached by other contract sales providers and have no hesitation in saying “no thank you.”
UK Commercial Director
"The collaboration with CHASE was instrumental in ensuring the study could be delivered on time and on budget.
In addition, CHASE facilitated, through site networks and agile research nurse placements, the delivery of the UK recruitment target 3 months ahead of plan."
Head of Clinical Operations UK & Ireland
Explore our latest thinking, event updates and industry insights in life sciences.
The NHS 10-year plan puts remote and virtual care at its centre. CHASE examines what that shift means for patients, the workforce and life sciences partners.
Cardiovascular disease is the NHS's big opportunity to save lives but earlier detection needs people, partnerships, and infrastructure. CHASE explores what that looks like in practice.
The Employment Rights Act 2025 is reshaping UK employment law in phases. Here’s what pharmaceutical, medtech, and NHS organisations need to know for 2026–27.
Tell us what you need to know. We’ll design an insight programme around your questions.
.svg)
